Correlation Between Cardio Diagnostics and Vaxcyte
Can any of the company-specific risk be diversified away by investing in both Cardio Diagnostics and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardio Diagnostics and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardio Diagnostics Holdings and Vaxcyte, you can compare the effects of market volatilities on Cardio Diagnostics and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardio Diagnostics with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardio Diagnostics and Vaxcyte.
Diversification Opportunities for Cardio Diagnostics and Vaxcyte
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cardio and Vaxcyte is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Cardio Diagnostics Holdings and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and Cardio Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardio Diagnostics Holdings are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of Cardio Diagnostics i.e., Cardio Diagnostics and Vaxcyte go up and down completely randomly.
Pair Corralation between Cardio Diagnostics and Vaxcyte
Given the investment horizon of 90 days Cardio Diagnostics Holdings is expected to generate 4.82 times more return on investment than Vaxcyte. However, Cardio Diagnostics is 4.82 times more volatile than Vaxcyte. It trades about 0.11 of its potential returns per unit of risk. Vaxcyte is currently generating about -0.1 per unit of risk. If you would invest 30.00 in Cardio Diagnostics Holdings on December 2, 2024 and sell it today you would earn a total of 15.00 from holding Cardio Diagnostics Holdings or generate 50.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Cardio Diagnostics Holdings vs. Vaxcyte
Performance |
Timeline |
Cardio Diagnostics |
Vaxcyte |
Cardio Diagnostics and Vaxcyte Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cardio Diagnostics and Vaxcyte
The main advantage of trading using opposite Cardio Diagnostics and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardio Diagnostics position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
Vaxcyte vs. Larimar Therapeutics | Vaxcyte vs. Syndax Pharmaceuticals | Vaxcyte vs. Merus BV | Vaxcyte vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |